Concepedia

Shayahati Bieerkehazhi

SB

Statistics

Publications

14

Citations

423

H-Index

13

Active since

2015

Affiliations

Xinjiang Medical University(Current)

Children's Cancer Center

Baylor College of Medicine

The University of Texas MD Anderson Cancer Center

Shanghai Tenth People's Hospital

Shayahati Bieerkehazhi is an author at Xinjiang Medical University specializing in molecular oncology, oncology, and medicine.

ORCID

Publications per year

2015–2021

14

Publications

14

Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity

Zhenghu Chen, Zhenyu Wang, Jonathan C. Pang et al. · Scientific Reports · 2016 · 82 citations · Full text

, , +12

The second-generation ALK inhibitor alectinib effectively induces apoptosis in human neuroblastoma cells and inhibits tumor growth in a TH-MYCN transgenic neuroblastoma mouse model

Jiaxiong Lu, Shan Guan, Yanling Zhao et al. · Cancer Letters · 2017 · 41 citations · Full text

, , +17

Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling

Shayahati Bieerkehazhi, Zhenghu Chen, Yanling Zhao et al. · Oncotarget · 2016 · 39 citations · Full text

, , +12

Second-generation proteasome inhibitor carfilzomib enhances doxorubicin-induced cytotoxicity and apoptosis in breast cancer cells

Yonghua Shi, Yang Yu, Zhenyu Wang et al. · Oncotarget · 2016 · 31 citations · Full text

, , +17

T cell receptor–dependent S-acylation of ZAP-70 controls activation of T cells

Ritika Tewari, Shayahati Bieerkehazhi, Ying Fan et al. · Journal of Biological Chemistry · 2021 · 30 citations · Full text

, , +17

1–5 of 14